{"ticker": {"uuid": "758d114c-0471-485d-989d-0bce3531a954", "symbol": "PYXS", "name": "Pyxis Oncology Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Pyxis Oncology: The Market Might Have Already Ruled On Micvotabart Pelidotin", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOMHRQZV9nN1FaeEtNRWY5WGwxdGtVY2FXcnhMN2Uxb3BIUHdfQ1duamxSWFRaQ0x4YXA2aC16SVZnWmRReXZieWFEN1hQcU1KZFVPQVR5VS00bjVDdjB3MHNyX0FlUzI0Z1lmdlhaaVFMZE00NFNxTHZIS05RZjY4ZTJOSnZyYjA1eHlfWEw2V2xmbWtzZXBFV2VnanJBUEVTOWl2S1lWeWJpOEZISjB4ZG9jZmJBLVU?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-14T14:05:33+00:00", "published_display": "14 Jul 2026 14:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) Declines Over 7%, Trading Near Critical Support Level - Passive Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQS2VJbGJXaUQxRzVjUE9DbmVhcXJDQWtjYW5BRTlrcEtiam13RlJPSnFuQzZIVHdVWHBmZHJRUXBocC1uUXM0cEVqaGQtZnVQMnZPLWV5YkYxZnM1U0ZyNWFLUXFGampsd0lsNjV2WXNTTy1rRkV0eGZwWGdUbUNfNlN6WERpOTRxTFE2cV9SQkdmazZ2SWFlRDQ2U0JhTEdaRGFKQkxpREJGalZoOTRuYmRn?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-13T19:31:01+00:00", "published_display": "13 Jul 2026 19:31", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Pyxis Oncology (PYXS) Revenue Breakdown - Main Composition", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moomoo", "published_at": "2026-07-11T01:26:26+00:00", "published_display": "11 Jul 2026 01:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (NASDAQ: PYXS) sees GordonMD entities report over 10M shares and large warrant stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOZXNicXByZDBmS05jY3lLejdsWlRtX1hOX3NSWGU5aEhXVDR6eTBvQ1JXemtaX3pVZXc2UHl4QlNsb21vaTNZbmI1YnJuMWs5Ujd1Sl9jbUZhOVBnVllWcjNWZDM4SS1YOVlZZDFiZXRLZmFFbWpja2J2WmtWQXhxM2xxMUR4NDRrb1NQNEZGcDRRQ0Q2RTFTLWNSdVd0em5JTFZRYWdQc3E0eHFRNEh0UFE5YVFfVHdxLTIweDViVTZjaDdPdEtjcw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T20:11:00+00:00", "published_display": "10 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Value Fund group (NASDAQ: PYXS) reports 9.99% capped stake in Pyxis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQMjhEdHdLM3BwT1JneXRrV3pYc0FNemFIa05uZl9XYnZCWnRLbjVtdzBhTUs4dlAxS0lMQnZnQnhvT05oQlZGSnhSTDYyN0dmMHpNUmp5a1AzUnpHZzdqeWtJSFpEdm5OX29mZzhrZ25SMmtFQjNRaFRNeVZWOXRaUU52YXhmM0NZX2hlbXAzc0RtUlBlVUVwRkxlM2FtS1NpU0xuT2dVRy1QaUM3WVRNZjdPck9ZeUY2MkJPRDkyaFVKaDA?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T20:08:36+00:00", "published_display": "10 Jul 2026 20:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Inc (NASDAQ: PYXS) Share Price, PYXS Stock News, PYXS Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE9RamlLOFRXS1prYTctdGhQRHJqZVcwS3p3OFc5Vm5xQ1RUSHJabVFYYjFCZ1dWTXc4SEtlQnpFdklJajVyVUFlYlRvdTFNeE1rWVNWaEZn?oc=5", "source_name": "Kalkine", "published_at": "2026-07-10T20:06:00+00:00", "published_display": "10 Jul 2026 20:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYXIS ONCOLOGY INC (PYXS) Stock Price & Overview", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE5oOENVQ3p2eWtBcV84MTg2bS1SbmsxT3Y3S25sMzk4N1hXd2hyS1NvZ3VBMzJsNV9GNnloNll4aTJDYU4zVjNpbnVleU1NU0wxUmR4YUQzcVh4VTkzUVE0?oc=5", "source_name": "ChartMill", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (NASDAQ: PYXS) raises up to $114M in private placement to fund MICVO trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOeDFnVzZGYUVUSVV2LTgxS3FTb1VEOGFCazFFMUl4ZUVYYWVMY3d3enNmQ0tLRjRVNnFLYWY2TGFOWXFWNjc0YU1WR2RaelJsZ0VYd0NFbUg4VTFaOWp2Si1HV3NaYlRpRDBNX1BvXy1WWXdRNGRzMWxqaUp2cGhJOHc5Q1A1VWQ0WE1JR2RZcTBSRU8yenAyVVRYaVNCSFdWc3NIR01pV0NpQzQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) director sells 35K shares after option exercise", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPWHBBdlMtTzZPWmRKaGJJOGpJeFV5NXhRMEtEVEF5Z3R0WmkyMTRPNkt1OERWUF9Kb0dqY29NMk52MWpQUTlzMUZ4a0NRT21iaWZiaUdJMXd5WXlvbV81MzgtYUhJUGIwdncwQ29ucVpaS0dQa1lyQ3VMeE5QRDVJM0d0bmpFVXcwYzA1ZHhrMW0xZFA5T0NZNVpxZ3o3NVFJRldXZFZ5NGs5SlFLV2dJeFB3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Secures Up to $114 Million Private Placement", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pyxis-oncology-secures-114-million-143054646.html", "source_name": "MT Newswires", "published_at": "2026-06-30T14:30:54+00:00", "published_display": "30 Jun 2026 14:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pyxis-oncology-announces-114-million-113000897.html", "source_name": "GlobeNewswire", "published_at": "2026-06-30T11:30:00+00:00", "published_display": "30 Jun 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology raises up to $114M to fund MICVO trial updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPcEhESW5BU1c4RDd6WTluQXdNUWg2alZqV2VINTNPN2Fka05XUUcxZXkxMHlXYU1GRG9UaDJSLUROWWJZYzlCWF92T1VQbk1PQVRvWmQta0ZkZ1JRRzNtUzRKbVpDYlkzcjFQLVloZ2dZY19Id25wSVZnQVExVEwxSzlzS0JzeVBiVjl2T1p0STEyR3pHNXhVc1dvSGRsWHUxOFFWR2VYZHBMSGdnWUxGaWdEOVdRdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Announces Up to $114 Million Private", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxQeWpvdXdyeVdfcU9jYUdnQkJYV090eUc3eTVTc3RQbkJIS3M0OFNJMEFGaDlncTdYYk05UU1IT0l2RzJPQWFTazRoUHJGR0NNWktmVG1uRXdrcHVYakVfeE1xblJpLXhCcWJfamZBdWhHQVRkWGREVFhwVkRYS2pIM3Nrck1aUWdjRmVMNndwanFIYmt4ZWtFOWZqcnR0elZvXzJnQzNnSU9JM1k0TjF2X2tTby1VaElFa2RZQmJVR0V0SldRUWJGdjZjMHI5ZUVrZEItaUsyckRkMzJESVZKSHFLYnVPbWdSREViYkM1TE9FZmRYRmk4WTRlSVpnNlVZVVpTS0k4Sl9uQ3VaQl9mdTdxU21VeUVUdTQw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Pyxis Oncology, Inc. SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQQ3FvejZMRFBjOG9hX2FMWVRmSnNrOHJXek0zejUxd1ZkMWtpcnBqUUJtbGE3SC1iV191aHNqUkxYMWNMVGxJZXhGQ3Y0TDBxMU9yVVc2NEwxTHJrRXFUOEw4aDRJZUFSN2VwOWh6Z1ZDXzloWDQtTE5xakhFd0Q4VUxJUXZTZHdMcVMzbjdyZ3dpckZTU05xcGVmaw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) shareholders elect Class II directors and ratify Ernst & Young as 2026 auditor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOM2t3QWRIRFZHeG82TXJpLWpCRmZrcDJTNzQyZTlSbGJma3RDQ1ZKRF9iUVY5T3B4NWVQdVFwbkRFYlJEN1NhdlUtLXNKb0dWR05JdDdUM1hjSjAwM0NmTW9DSFctN2ZtMVRwNi1FZzRaQ2pEdDAwdzF5cTZTOG1DdGl1YjA1eWxSaTZVTnhhMHlETF9jUGExQUswZjY2TkxVZklaTEl0N09ZTnM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts See Nearly 3X Upside in Pyxis Oncology (PYXS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPM2NtbE9xbGtSOHM1OU14ZU1KREwyNDRnelNPdDE4cGZBdW5VUFlNbjd2WVNXTHJ2M25JNWZNZmFtWk5lUVA0TzBiNFFNT3hHaU9SUHdzeC1taXpsTS03UW9LeUZCSWlSUEc2QXVPVVZKNnlsam9YcmhsTWY4OTRnN2FZUWo3a1NIcWRlWkQ1Y2hPMkdQUjdtMU9Ec1A2Z3c?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) Cash Runway Under One Year Reinforces Bearish Funding Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/pyxis-oncology-reports-first-quarter-110000535.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T11:00:00+00:00", "published_display": "14 May 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAJBVV95cUxNcGYwN2xDMVlMaDRTa1ZGNGhQdnZHTXVjRXFSMU90V2puc3dIU1pDWnlpVkpnVEpaTGtEZDktQ0RiSlNiSDVFdnQ1TnFxZ2x1Z3RQU3Q3NVgtaG0yS1Z1ZjduMVFiTlZpNHVZcDdsN1kza0ZQdGFkWWgtc1JoMHhQazU2MzR6R2FwS09CWDRrVU1iZFJFOHdPWkNQRjdJT2cyODhWVGkzRXhINWh1VEFiYWlYaGpjblhvWHJLVXFObFRlNVNhdnRvSkVmYXM3WFJlQVB0NkN0cmJQeGx1WnVxVmJlb2ZfbkYycmpDU2Jqb09faFhZeDd0Yy1ldE5VZndzWjg0M2ZERHhEa3lXbDVvQlZlWHo?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Pyxis Oncology to Participate in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/news/pyxis-oncology-participate-upcoming-investor-113000825.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T11:30:00+00:00", "published_display": "13 May 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/pyxis-oncology-appoints-nelson-azoulay-200500955.html", "source_name": "GlobeNewswire", "published_at": "2026-05-07T20:05:00+00:00", "published_display": "07 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis brings in former ImmunoGen dealmaker to advance MICVO", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPbGJkTDlkejlNOTA3a0VjaEFRLVNSdFlvdVBIaHBqZHEzSUtneTBLek5HUV9yQldjNHhyMmt5dEhWOHlaeXhkajNraUo5RTNTZ1hQakFDcjVza1piSXlJaXFjTm9iUHYxcEx5SnItRXJXY2N6YmhtSzczME80eXhpSmM5VnZTOTRFNlZUejdsY2RfR0lvdE41Slo0ajZGbGxybDZJTDRjV211c2wwcWtsaQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wedbush Initiates Pyxis Oncology at Outperform With $6 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wedbush-initiates-pyxis-oncology-outperform-113309759.html", "source_name": "MT Newswires", "published_at": "2026-05-05T11:33:09+00:00", "published_display": "05 May 2026 11:33", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/pyxis-oncology-present-preclinical-data-200500236.html", "source_name": "GlobeNewswire", "published_at": "2026-04-17T20:05:00+00:00", "published_display": "17 Apr 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYXS | Pyxis Oncology, Inc. Common Insider Trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBhLWdFWVBoOGhDVDhYUG5iUEQyOWV1Zm9ybERXeUItQTYxNnNuVmx1LTFTNjE0YWxGSXJfTGVYMjFna3dVcGFIeV9RM05vRVVJQ0RNdFhGTHpMd3Yz?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-12T09:51:19+00:00", "published_display": "12 Apr 2026 09:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Pyxis fills head and neck cancer study, says cash lasts into Q4", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOYzFCZmFPNGVPX18yVVFXbC1KTHlSQnpadkExLUQ1a08takl5WUNTVHRjeXNXUDdNZWpTdlFVcnlwSmh5UXhYTHZ4UWNfQXNxNVFiNG9jcDREdFN5REVKV001QzNaTGxWdkdPS202NHhxdXcxVnJMeHkwM3otbTh3T05KTGM4WUo0QnB0S2hMUWs0QUE0ZTAxVXhOTGlSOXl2WW1sZ24yWUczbVVweVp1aG5sNldYczF5QmhXZ3N3?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBMUHF0V2lyNFJsTGxHeUZvYnZ4UWhJeU0taUhyMHFSSzBuWE13end1OFNrZThfU1hVVDdjM1dxNG5iUVUwMTF0QUxiVjVtX2ZlOUpZ?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:33:43+00:00", "published_display": "25 Apr 2025 00:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) Stock Price, News & Analysis $PYXS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBjTlljSFk0VHFhWUstdGF3dG9vdk9RbHdacW84SDFmMS1TTTlDS3kxTEV5b2QwdlBUZHFiOG1ta09KczFjTlpKQkp0enkyRlpDcGRKbndSNEstZw?oc=5", "source_name": "MarketBeat", "published_at": "2021-10-09T15:53:05+00:00", "published_display": "09 Oct 2021 15:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Pyxis Oncology: The Market Might Have Already Ruled On Micvotabart Pelidotin", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOMHRQZV9nN1FaeEtNRWY5WGwxdGtVY2FXcnhMN2Uxb3BIUHdfQ1duamxSWFRaQ0x4YXA2aC16SVZnWmRReXZieWFEN1hQcU1KZFVPQVR5VS00bjVDdjB3MHNyX0FlUzI0Z1lmdlhaaVFMZE00NFNxTHZIS05RZjY4ZTJOSnZyYjA1eHlfWEw2V2xmbWtzZXBFV2VnanJBUEVTOWl2S1lWeWJpOEZISjB4ZG9jZmJBLVU?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-14T14:05:33+00:00", "published_display": "14 Jul 2026 14:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) Declines Over 7%, Trading Near Critical Support Level - Passive Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQS2VJbGJXaUQxRzVjUE9DbmVhcXJDQWtjYW5BRTlrcEtiam13RlJPSnFuQzZIVHdVWHBmZHJRUXBocC1uUXM0cEVqaGQtZnVQMnZPLWV5YkYxZnM1U0ZyNWFLUXFGampsd0lsNjV2WXNTTy1rRkV0eGZwWGdUbUNfNlN6WERpOTRxTFE2cV9SQkdmazZ2SWFlRDQ2U0JhTEdaRGFKQkxpREJGalZoOTRuYmRn?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-13T19:31:01+00:00", "published_display": "13 Jul 2026 19:31", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) Revenue Breakdown - Main Composition", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moomoo", "published_at": "2026-07-11T01:26:26+00:00", "published_display": "11 Jul 2026 01:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (NASDAQ: PYXS) sees GordonMD entities report over 10M shares and large warrant stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOZXNicXByZDBmS05jY3lLejdsWlRtX1hOX3NSWGU5aEhXVDR6eTBvQ1JXemtaX3pVZXc2UHl4QlNsb21vaTNZbmI1YnJuMWs5Ujd1Sl9jbUZhOVBnVllWcjNWZDM4SS1YOVlZZDFiZXRLZmFFbWpja2J2WmtWQXhxM2xxMUR4NDRrb1NQNEZGcDRRQ0Q2RTFTLWNSdVd0em5JTFZRYWdQc3E0eHFRNEh0UFE5YVFfVHdxLTIweDViVTZjaDdPdEtjcw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T20:11:00+00:00", "published_display": "10 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Value Fund group (NASDAQ: PYXS) reports 9.99% capped stake in Pyxis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQMjhEdHdLM3BwT1JneXRrV3pYc0FNemFIa05uZl9XYnZCWnRLbjVtdzBhTUs4dlAxS0lMQnZnQnhvT05oQlZGSnhSTDYyN0dmMHpNUmp5a1AzUnpHZzdqeWtJSFpEdm5OX29mZzhrZ25SMmtFQjNRaFRNeVZWOXRaUU52YXhmM0NZX2hlbXAzc0RtUlBlVUVwRkxlM2FtS1NpU0xuT2dVRy1QaUM3WVRNZjdPck9ZeUY2MkJPRDkyaFVKaDA?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T20:08:36+00:00", "published_display": "10 Jul 2026 20:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Inc (NASDAQ: PYXS) Share Price, PYXS Stock News, PYXS Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE9RamlLOFRXS1prYTctdGhQRHJqZVcwS3p3OFc5Vm5xQ1RUSHJabVFYYjFCZ1dWTXc4SEtlQnpFdklJajVyVUFlYlRvdTFNeE1rWVNWaEZn?oc=5", "source_name": "Kalkine", "published_at": "2026-07-10T20:06:00+00:00", "published_display": "10 Jul 2026 20:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYXIS ONCOLOGY INC (PYXS) Stock Price & Overview", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE5oOENVQ3p2eWtBcV84MTg2bS1SbmsxT3Y3S25sMzk4N1hXd2hyS1NvZ3VBMzJsNV9GNnloNll4aTJDYU4zVjNpbnVleU1NU0wxUmR4YUQzcVh4VTkzUVE0?oc=5", "source_name": "ChartMill", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (NASDAQ: PYXS) raises up to $114M in private placement to fund MICVO trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOeDFnVzZGYUVUSVV2LTgxS3FTb1VEOGFCazFFMUl4ZUVYYWVMY3d3enNmQ0tLRjRVNnFLYWY2TGFOWXFWNjc0YU1WR2RaelJsZ0VYd0NFbUg4VTFaOWp2Si1HV3NaYlRpRDBNX1BvXy1WWXdRNGRzMWxqaUp2cGhJOHc5Q1A1VWQ0WE1JR2RZcTBSRU8yenAyVVRYaVNCSFdWc3NIR01pV0NpQzQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) director sells 35K shares after option exercise", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPWHBBdlMtTzZPWmRKaGJJOGpJeFV5NXhRMEtEVEF5Z3R0WmkyMTRPNkt1OERWUF9Kb0dqY29NMk52MWpQUTlzMUZ4a0NRT21iaWZiaUdJMXd5WXlvbV81MzgtYUhJUGIwdncwQ29ucVpaS0dQa1lyQ3VMeE5QRDVJM0d0bmpFVXcwYzA1ZHhrMW0xZFA5T0NZNVpxZ3o3NVFJRldXZFZ5NGs5SlFLV2dJeFB3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Secures Up to $114 Million Private Placement", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pyxis-oncology-secures-114-million-143054646.html", "source_name": "MT Newswires", "published_at": "2026-06-30T14:30:54+00:00", "published_display": "30 Jun 2026 14:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pyxis-oncology-announces-114-million-113000897.html", "source_name": "GlobeNewswire", "published_at": "2026-06-30T11:30:00+00:00", "published_display": "30 Jun 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology raises up to $114M to fund MICVO trial updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPcEhESW5BU1c4RDd6WTluQXdNUWg2alZqV2VINTNPN2Fka05XUUcxZXkxMHlXYU1GRG9UaDJSLUROWWJZYzlCWF92T1VQbk1PQVRvWmQta0ZkZ1JRRzNtUzRKbVpDYlkzcjFQLVloZ2dZY19Id25wSVZnQVExVEwxSzlzS0JzeVBiVjl2T1p0STEyR3pHNXhVc1dvSGRsWHUxOFFWR2VYZHBMSGdnWUxGaWdEOVdRdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Announces Up to $114 Million Private", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxQeWpvdXdyeVdfcU9jYUdnQkJYV090eUc3eTVTc3RQbkJIS3M0OFNJMEFGaDlncTdYYk05UU1IT0l2RzJPQWFTazRoUHJGR0NNWktmVG1uRXdrcHVYakVfeE1xblJpLXhCcWJfamZBdWhHQVRkWGREVFhwVkRYS2pIM3Nrck1aUWdjRmVMNndwanFIYmt4ZWtFOWZqcnR0elZvXzJnQzNnSU9JM1k0TjF2X2tTby1VaElFa2RZQmJVR0V0SldRUWJGdjZjMHI5ZUVrZEItaUsyckRkMzJESVZKSHFLYnVPbWdSREViYkM1TE9FZmRYRmk4WTRlSVpnNlVZVVpTS0k4Sl9uQ3VaQl9mdTdxU21VeUVUdTQw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Pyxis Oncology, Inc. SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQQ3FvejZMRFBjOG9hX2FMWVRmSnNrOHJXek0zejUxd1ZkMWtpcnBqUUJtbGE3SC1iV191aHNqUkxYMWNMVGxJZXhGQ3Y0TDBxMU9yVVc2NEwxTHJrRXFUOEw4aDRJZUFSN2VwOWh6Z1ZDXzloWDQtTE5xakhFd0Q4VUxJUXZTZHdMcVMzbjdyZ3dpckZTU05xcGVmaw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) shareholders elect Class II directors and ratify Ernst & Young as 2026 auditor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOM2t3QWRIRFZHeG82TXJpLWpCRmZrcDJTNzQyZTlSbGJma3RDQ1ZKRF9iUVY5T3B4NWVQdVFwbkRFYlJEN1NhdlUtLXNKb0dWR05JdDdUM1hjSjAwM0NmTW9DSFctN2ZtMVRwNi1FZzRaQ2pEdDAwdzF5cTZTOG1DdGl1YjA1eWxSaTZVTnhhMHlETF9jUGExQUswZjY2TkxVZklaTEl0N09ZTnM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts See Nearly 3X Upside in Pyxis Oncology (PYXS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPM2NtbE9xbGtSOHM1OU14ZU1KREwyNDRnelNPdDE4cGZBdW5VUFlNbjd2WVNXTHJ2M25JNWZNZmFtWk5lUVA0TzBiNFFNT3hHaU9SUHdzeC1taXpsTS03UW9LeUZCSWlSUEc2QXVPVVZKNnlsam9YcmhsTWY4OTRnN2FZUWo3a1NIcWRlWkQ1Y2hPMkdQUjdtMU9Ec1A2Z3c?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) Cash Runway Under One Year Reinforces Bearish Funding Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/pyxis-oncology-reports-first-quarter-110000535.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T11:00:00+00:00", "published_display": "14 May 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAJBVV95cUxNcGYwN2xDMVlMaDRTa1ZGNGhQdnZHTXVjRXFSMU90V2puc3dIU1pDWnlpVkpnVEpaTGtEZDktQ0RiSlNiSDVFdnQ1TnFxZ2x1Z3RQU3Q3NVgtaG0yS1Z1ZjduMVFiTlZpNHVZcDdsN1kza0ZQdGFkWWgtc1JoMHhQazU2MzR6R2FwS09CWDRrVU1iZFJFOHdPWkNQRjdJT2cyODhWVGkzRXhINWh1VEFiYWlYaGpjblhvWHJLVXFObFRlNVNhdnRvSkVmYXM3WFJlQVB0NkN0cmJQeGx1WnVxVmJlb2ZfbkYycmpDU2Jqb09faFhZeDd0Yy1ldE5VZndzWjg0M2ZERHhEa3lXbDVvQlZlWHo?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology to Participate in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/news/pyxis-oncology-participate-upcoming-investor-113000825.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T11:30:00+00:00", "published_display": "13 May 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/pyxis-oncology-appoints-nelson-azoulay-200500955.html", "source_name": "GlobeNewswire", "published_at": "2026-05-07T20:05:00+00:00", "published_display": "07 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis brings in former ImmunoGen dealmaker to advance MICVO", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPbGJkTDlkejlNOTA3a0VjaEFRLVNSdFlvdVBIaHBqZHEzSUtneTBLek5HUV9yQldjNHhyMmt5dEhWOHlaeXhkajNraUo5RTNTZ1hQakFDcjVza1piSXlJaXFjTm9iUHYxcEx5SnItRXJXY2N6YmhtSzczME80eXhpSmM5VnZTOTRFNlZUejdsY2RfR0lvdE41Slo0ajZGbGxybDZJTDRjV211c2wwcWtsaQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wedbush Initiates Pyxis Oncology at Outperform With $6 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wedbush-initiates-pyxis-oncology-outperform-113309759.html", "source_name": "MT Newswires", "published_at": "2026-05-05T11:33:09+00:00", "published_display": "05 May 2026 11:33", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/pyxis-oncology-present-preclinical-data-200500236.html", "source_name": "GlobeNewswire", "published_at": "2026-04-17T20:05:00+00:00", "published_display": "17 Apr 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PYXS | Pyxis Oncology, Inc. Common Insider Trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBhLWdFWVBoOGhDVDhYUG5iUEQyOWV1Zm9ybERXeUItQTYxNnNuVmx1LTFTNjE0YWxGSXJfTGVYMjFna3dVcGFIeV9RM05vRVVJQ0RNdFhGTHpMd3Yz?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-12T09:51:19+00:00", "published_display": "12 Apr 2026 09:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis fills head and neck cancer study, says cash lasts into Q4", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOYzFCZmFPNGVPX18yVVFXbC1KTHlSQnpadkExLUQ1a08takl5WUNTVHRjeXNXUDdNZWpTdlFVcnlwSmh5UXhYTHZ4UWNfQXNxNVFiNG9jcDREdFN5REVKV001QzNaTGxWdkdPS202NHhxdXcxVnJMeHkwM3otbTh3T05KTGM4WUo0QnB0S2hMUWs0QUE0ZTAxVXhOTGlSOXl2WW1sZ24yWUczbVVweVp1aG5sNldYczF5QmhXZ3N3?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBMUHF0V2lyNFJsTGxHeUZvYnZ4UWhJeU0taUhyMHFSSzBuWE13end1OFNrZThfU1hVVDdjM1dxNG5iUVUwMTF0QUxiVjVtX2ZlOUpZ?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:33:43+00:00", "published_display": "25 Apr 2025 00:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyxis Oncology (PYXS) Stock Price, News & Analysis $PYXS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBjTlljSFk0VHFhWUstdGF3dG9vdk9RbHdacW84SDFmMS1TTTlDS3kxTEV5b2QwdlBUZHFiOG1ta09KczFjTlpKQkp0enkyRlpDcGRKbndSNEstZw?oc=5", "source_name": "MarketBeat", "published_at": "2021-10-09T15:53:05+00:00", "published_display": "09 Oct 2021 15:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 73, "total_relevant": 36, "sentiment_summary": {"positive": 5, "negative": 3, "neutral": 28, "score": 50, "total": 36, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 11.35, "count": 20}, {"event": "earnings", "label": "Earnings", "weight": 4.95, "count": 11}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 5, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 2.67, "latest_week": "2026-07-10", "one_week_move": 1.5, "four_week_move": 51.7, "twelve_week_move": 60.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.208624, "market_dynamics_buy_signal": false, "relative_strength": 6.288079, "fair_value_gap": 8.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 47.4295, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.5% over one week, +51.7% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 10}, {"label": "GlobeNewswire", "count": 7}, {"label": "Market source", "count": 6}, {"label": "simplywall.st", "count": 3}, {"label": "MT Newswires", "count": 2}, {"label": "Seeking Alpha", "count": 1}, {"label": "dars.gov.et", "count": 1}, {"label": "Moomoo", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 28}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 20}, {"label": "Earnings", "count": 11}, {"label": "Deals and strategy", "count": 2}, {"label": "Balance sheet", "count": 2}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "28", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+1.5% over one week, +51.7% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Pyxis Oncology: The Market Might Have Already Ruled On Micvotabart Pelidotin"}], "updated_at": "2026-07-16T03:29:54.901340+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}